News headlines about Envision Healthcare (NYSE:EVHC) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Envision Healthcare earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 48.010361024945 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Several equities research analysts have recently weighed in on the company. Zacks Investment Research raised Envision Healthcare from a “hold” rating to a “buy” rating and set a $46.00 target price for the company in a research report on Friday, May 11th. Canaccord Genuity upped their target price on Envision Healthcare from $46.00 to $48.00 and gave the stock a “buy” rating in a research report on Wednesday, May 9th. ValuEngine downgraded Envision Healthcare from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 2nd. SunTrust Banks increased their price target on Envision Healthcare to $45.00 and gave the company a “buy” rating in a report on Thursday, March 1st. Finally, Mizuho set a $38.00 price target on Envision Healthcare and gave the company a “hold” rating in a report on Friday, March 2nd. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $41.10.
Shares of Envision Healthcare opened at $42.00 on Friday, according to MarketBeat Ratings. The stock has a market capitalization of $5.14 billion, a P/E ratio of 16.94, a price-to-earnings-growth ratio of 0.97 and a beta of 0.43. Envision Healthcare has a one year low of $23.77 and a one year high of $64.00. The company has a quick ratio of 2.25, a current ratio of 2.27 and a debt-to-equity ratio of 0.65.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Monday, May 7th. The company reported $0.71 EPS for the quarter, beating analysts’ consensus estimates of $0.64 by $0.07. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The firm had revenue of $2.08 billion during the quarter, compared to the consensus estimate of $2.02 billion. During the same quarter in the prior year, the business posted $0.77 earnings per share. Envision Healthcare’s revenue for the quarter was up 10.6% on a year-over-year basis. research analysts anticipate that Envision Healthcare will post 3.39 EPS for the current year.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.